XONELITY Trademark

Trademark Overview

On Monday, July 10, 2017, a trademark application was filed for XONELITY with the United States Patent and Trademark Office. The USPTO has given the XONELITY trademark a serial number of 87522017. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 22, 2021. This trademark is owned by Alkermes Pharma Ireland Limited. The XONELITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases including schizophrenia, depression, major depressive disorder, treatment resistant depression, bipolar depression, bipolar disorder, mitigation of weight gain, metabolic diseases and dyslipidemia
xonelity

General Information

Serial Number87522017
Word MarkXONELITY
Filing DateMonday, July 10, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 22, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 21, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases including schizophrenia, depression, major depressive disorder, treatment resistant depression, bipolar depression, bipolar disorder, mitigation of weight gain, metabolic diseases and dyslipidemia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, July 15, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlkermes Pharma Ireland Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDUBLIN
IE
Party NameAlkermes Pharma Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDUBLIN
IE

Trademark Events

Event DateEvent Description
Monday, February 22, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 22, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, June 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 18, 2020EXTENSION 5 GRANTED
Tuesday, June 2, 2020EXTENSION 5 FILED
Thursday, June 18, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 2, 2020TEAS EXTENSION RECEIVED
Saturday, October 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 17, 2019EXTENSION 4 GRANTED
Thursday, October 17, 2019EXTENSION 4 FILED
Thursday, October 17, 2019TEAS EXTENSION RECEIVED
Wednesday, May 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 20, 2019EXTENSION 3 GRANTED
Monday, May 20, 2019EXTENSION 3 FILED
Monday, May 20, 2019TEAS EXTENSION RECEIVED
Saturday, January 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 3, 2019EXTENSION 2 GRANTED
Thursday, January 3, 2019EXTENSION 2 FILED
Thursday, January 3, 2019TEAS EXTENSION RECEIVED
Friday, June 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 20, 2018EXTENSION 1 GRANTED
Wednesday, June 20, 2018EXTENSION 1 FILED
Wednesday, June 20, 2018TEAS EXTENSION RECEIVED
Tuesday, January 16, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 21, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 21, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 1, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 10, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 5, 2017ASSIGNED TO EXAMINER
Saturday, July 15, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 13, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

xonelity depression bipolar disorder diseases treatment dyslipidemia resistant mitigation metabolic weight